79: Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Episode Description Although neurotrophic keratitis (NK) is considered a rare eye disease, it is a degenerative corneal disease that can profoundly affect patients' lives. Left untreated, NK can lead to corneal ulceration, melting, and perforation, which can ultimately lead to vision loss. In this podcast, experts Quan Dong Nguyen, MD, MSc; and Cecelia Koetting, OD, FAAO, DipABO; discuss the diagnosis, staging, and treatment of NK, focusing on early-stage disease. Acknowledgment of Educational Grant SupportThis activity is supported by an educational grant from Dompé US, Inc.Quan Dong Nguyen, MD, MSc Professor of OphthalmologyByers Eye Institute, Stanford University School of MedicineStanford, CADisclosure: Research Support: Active Biotech, Genentech, Oculis, Priovant, Regeneron; Advisory Boards: Kriya, Oculis, Priovant, Regeneron.Cecelia Koetting, OD, FAAO, DipABOClinical InstructorDepartment of OphthalmologyUniversity of Colorado School of MedicineDenver, CODisclosure: Grant Support: KALA BIO, Ocular Therapeutix, Tarsus Pharmaceuticals, Viatris; Consultant: AbbVie, Alcon, Aldeyra Therapeutics, Azura Ophthalmics, Bausch + Lomb, Blinkjoy, Bruder Healthcare, Dompé US, Glaukos, Myze, Orasis Pharmaceuticals, Sight Sciences, Tarsus Pharmaceuticals, Théa Pharma, Topcon Healthcare, Twenty/Twenty, Verséa Ophthalmics, Visus Therapeutics; Speaker’s bureau: Alcon, Bausch + Lomb, Dompé US, Glaukos, Harrow, Viatris, Sight Sciences.Faculty, Staff, and Planners’ DisclosuresIn accordance with ACCME Guidelines, PER® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies. This podcast was developed by PER® editorial staff based on an online activity developed with these faculty. To learn more about this topic, including information on the diagnosis, testing, and management of patients with NK, go to https://www.gotoper.com/courses/neurotrophic-keratitis-multidisciplinary-approaches-to-enhance-patient-outcomesRelease DateJune 30, 2025Expiration DateJune 30, 2026 Off-Label Disclosure and DisclaimerThis activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.